Get the Stockscreener App
2.68
3.94%
-0.11
After Hours:
2.76
0.08
+2.99%
Stereotaxis Inc stock is traded at $2.68, with a volume of 416.32K.
It is down -3.94% in the last 24 hours and up +12.61% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.79
Open:
$2.79
24h Volume:
416.32K
Relative Volume:
0.75
Market Cap:
$250.11M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-9.9259
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
+6.77%
1M Performance:
+12.61%
6M Performance:
+12.13%
1Y Performance:
+27.62%
1-Day Range:
$2.68
$2.82
1-Week Range:
$2.47
$2.86
52-Week Range:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.68 | 260.38M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
535.00 | 191.90B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
207.11 | 59.36B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.00 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
257.58 | 38.05B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.12 | 33.62B | 27.43B | 1.27B | 1.01B | 1.5829 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Insider Sell: Is Stereotaxis Inc stock resilient to inflationQuarterly Risk Review & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Robotics in EP and Cath Labs - Diagnostic and Interventional Cardiology
What sentiment indicators say about Stereotaxis Inc. stockPortfolio Return Report & Accurate Intraday Trading Signals - Улправда
Why Stereotaxis Inc. stock is popular among millennials2025 AllTime Highs & Real-Time Chart Pattern Alerts - ulpravda.ru
Is Stereotaxis Inc. stock cheap by valuation metricsJuly 2025 Institutional & Technical Buy Zone Confirmations - Улправда
Is Stereotaxis Inc. stock positioned for digital transformationJuly 2025 Chart Watch & Long Hold Capital Preservation Tips - Улправда
St. Louis-based Stereotaxis gets FDA nod for robotic heart device central to growth strategy - The Business Journals
How Stereotaxis Inc. stock performs during Fed tightening cyclesEarnings Per Share Trends & Big Returns, Small Investment – Learn How - Улправда
Analysts Offer Insights on Healthcare Companies: Candel Therapeutics (CADL) and Stereotaxis (STXS) - The Globe and Mail
Stereotaxis wins FDA approval for robotically navigated ablation catheter - MedTech Dive
Stereotaxis (NYSEAMERICAN:STXS) Trading 8.1% HigherWhat's Next? - MarketBeat
Stereotaxis’ Magic magnetic ablation gets FDA nod - BioWorld MedTech
Stereotaxis stock soars after FDA approval of robotic ablation catheter By Investing.com - Investing.com Canada
Stereotaxis Wins Approval for MAGic Catheter - Medical Device and Diagnostic industry
Stereotaxis Shares Advance on FDA Approval for Magnetic Catheter - marketscreener.com
Stereotaxis Wins FDA Nod for MAGiC Magnetic Ablation Catheter - Medical Product Outsourcing
Stereotaxis Says US FDA Approves MAGiC Magnetic Interventional Ablation Catheter - marketscreener.com
Stereotaxis receives FDA approval for Magic ablation catheter - marketscreener.com
Stereotaxis (STXS) Gains FDA Approval for MAGiC Ablation Catheter - GuruFocus
Stereotaxis Says FDA Approves MAGiC Magnetic Interventional Ablation Catheter - Nasdaq
Stereotaxis gets FDA approval for magnetic ablation catheter By Investing.com - Investing.com India
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter - GlobeNewswire
FDA approves MAGiC robotic heart catheter to treat complex arrhythmias - Stock Titan
STXSStereotaxis Reports 2019 Third Quarter Financial Results - ADVFN
Signal Recap: Can Stereotaxis Inc stock sustain free cash flow growthJuly 2025 Drop Watch & Consistent Profit Trading Strategies - Bộ Nội Vụ
Robotic Catheterization Systems Market | Global Market Analysis Report2036 - Future Market Insights
The Blend of CEO & Investor Synergy in Stereotaxis - Medical Device and Diagnostic industry
How Stereotaxis Inc. stock compares with top peersJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Улправда
Stereotaxis shares drop after Q3 loss widens, GenesisX limited launch underway - MSN
Will Stereotaxis Inc. stock deliver long term returns2025 Technical Patterns & Momentum Based Trading Ideas - DonanımHaber
How Stereotaxis Inc. stock valuation compares with sector2025 Risk Factors & Daily Volume Surge Signals - Улправда
CEO Moves: Why Stereotaxis Inc. stock is popular among millennialsJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - moha.gov.vn
Stereotaxis (NYSEAMERICAN:STXS) Now Covered by Citizens Jmp - Defense World
Citizens Jmp Begins Coverage on Stereotaxis (NYSEAMERICAN:STXS) - MarketBeat
This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Sahm
Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - Nasdaq
Stereotaxis (STXS): Analyst Initiates Coverage with "Market Outp - GuruFocus
Citizens initiates Stereotaxis stock with Market Outperform rating on robotic surgery growth - Investing.com India
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.1%Here's Why - MarketBeat
Stereotaxis (NYSEAMERICAN:STXS) Shares Down 2.1% – Here’s Why - Defense World
3 Underrated Robotics Stocks Poised for Huge Gains - Finviz
Short Squeeze: Why Stereotaxis Inc stock is a strong analyst pickJuly 2025 Retail & AI Enhanced Execution Alerts - moha.gov.vn
Why Stereotaxis Inc. stock could be top winner2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Is Stereotaxis Inc. stock vulnerable to rate hikesWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Published on: 2025-12-05 00:51:23 - Newser
Published on: 2025-12-04 13:10:01 - Newser
Stereotaxis Inc (STXS) is looking forward to a strong quarter - Setenews
Why analysts maintain buy rating on Stereotaxis Inc. stock2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Can Stereotaxis Inc. stock hold up in economic slowdownOptions Play & Long-Term Investment Growth Plans - Newser
Stereotaxis, Inc. (STXS) -5.5% in After-hours: Trading Amid Routine Activity - Stocks Telegraph
How Stereotaxis Inc. stock correlates with oil marketsJuly 2025 Patterns & Weekly Top Gainers Trade List - Newser
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):